Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs The agreement includes proposed biosimilars to ...

After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...